About the Company
We do not have any company description for OmniAb Inc at the moment.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OABI News
OmniAb Inc (NASDAQ: OABI) Analysts Expect It Could Climb 66.8% From Current Levels.
The trading price of OmniAb Inc (NASDAQ:OABI) closed lower on Friday, March 17, closing at $3.43, -2.83% lower than its previous close. Traders who pay close attention to intraday price movement ...
Thinking Of Buying OmniAb Inc (NASDAQ: OABI) Stock? Here’s What You Need To Know
OmniAb Inc (NASDAQ:OABI) price on Wednesday, March 15, rose 3.37% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.68. A look at the stock’s price ...
OmniAb: Legitimate Competition To AbCellera In Antibody Discovery
OmniAb recently completed its separation from Ligand Pharmaceuticals and is now a publicly traded independent company solely focused on antibody discovery partnerships. OmniAb utilizes what it ...
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, March 30, 2023 and will ...
OmniAb Inc (OABI) Stock: A Value Analysis
Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.” The public float for OABI is 93.62M and currently, short sellers ...
10-K: LIGAND PHARMACEUTICALS INC
and OmniAb, Inc., a Delaware corporation and then wholly-owned subsidiary of our company (OmniAb), and Orwell Merger Sub Inc. (Merger Sub), pursuant to which New OmniAb combined with OmniAb ...
OmniAb to Participate in Three Upcoming Investor Conferences
EMERYVILLE, Calif., February 07, 2023--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three upcoming investor conferences. SVB Securities Global ...
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30
EMERYVILLE, Calif., (BUSINESS WIRE) -- OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S. financial markets ...
OmniAb to Report Fourth Quarter 2022 Financial Results on March 30
EMERYVILLE, Calif., March 09, 2023--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2022 after the close of the U.S ...
Loading the latest forecasts...